125 related articles for article (PubMed ID: 72289)
1. Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen.
Meade TW; Haines AP; North WR; Chakrabarti R; Howarth DJ; Stirling Y
Lancet; 1977 Nov; 2(8045):948-51. PubMed ID: 72289
[TBL] [Abstract][Full Text] [Related]
2. An epidemiological study of the haemostatic and other effects of oral contraceptives.
Meade TW; Brozović M; Chakrabarth R; Howarth DJ; North WR; Stirling Y
Br J Haematol; 1976 Nov; 34(3):353-64. PubMed ID: 990177
[TBL] [Abstract][Full Text] [Related]
3. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
Nash AL; Cornish EJ; Hain R
Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulaion
Contraception; 2003 Sep; 68(3):159-76. PubMed ID: 14561536
[TBL] [Abstract][Full Text] [Related]
5. A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives.
Briggs MH
J Reprod Med; 1983 Jan; 28(1 Suppl):92-9. PubMed ID: 6403706
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptive estrogen and plasma lipid levels.
Hedlin A; Kuksis A; Geher K
Obstet Gynecol; 1978 Oct; 52(4):430-5. PubMed ID: 714324
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
Sabra A; Bonnar J
J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
[TBL] [Abstract][Full Text] [Related]
8. Effects of progestogen oral contraception with norethisterone on blood clotting and platelets.
Poller L; Thomson JM; Thomas PW
Br Med J; 1972 Nov; 4(5837):391-3. PubMed ID: 4118012
[TBL] [Abstract][Full Text] [Related]
9. Effect of synthetic oestrogens and progestagens in oral contraceptives on bile lipid composition.
Down RH; Whiting MJ; Watts JM; Jones W
Gut; 1983 Mar; 24(3):253-9. PubMed ID: 6826111
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of some blood clotting parameters in relation to the administration of estroprogestins].
Orlandi F; Cattaneo C; Gabasio S; Spandre M; Paccotti P; Rustichelli S
Arch Sci Med (Torino); 1978; 135(4):609-17. PubMed ID: 756722
[TBL] [Abstract][Full Text] [Related]
11. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
12. Progestational agents and blood coagulation. II.
Ambrus JL; Niswander KR; Courey NG; Wamsteker EF; Mink IB
Am J Obstet Gynecol; 1969 Apr; 103(7):994-1001. PubMed ID: 5774681
[No Abstract] [Full Text] [Related]
13. Progestagen-only oral contraceptives: comparison of the metabolic effects of levonorgestrel and norethisterone.
Ball MJ; Ashwell E; Gillmer MD
Contraception; 1991 Sep; 44(3):223-33. PubMed ID: 1764941
[TBL] [Abstract][Full Text] [Related]
14. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
15. Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?
Brosnan JF; Sheppard BL; Norris LA
Thromb Haemost; 2007 Apr; 97(4):558-65. PubMed ID: 17393018
[TBL] [Abstract][Full Text] [Related]
16. Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.
Rákóczi I; Gerö G; Demeter J; Gáti I
Arzneimittelforschung; 1985; 35(3):630-3. PubMed ID: 3158320
[TBL] [Abstract][Full Text] [Related]
17. Progestational agents and blood coagulation. VI. Relationship of ABO blood types to changes induced by oral contraceptives.
Lillie MA; Mink IB
Am J Obstet Gynecol; 1974 Jun; 119(3):406-10. PubMed ID: 4827381
[TBL] [Abstract][Full Text] [Related]
18. A study of the effect of an oral contraceptive on blood coagulation factors, platelets and fibrinolytic activity.
Medhat IA; Toppozada HK; Rizk MA; Khowessah MM; Malek AT; Moghazi M
Contraception; 1974 Apr; 9(4):379-92. PubMed ID: 4442281
[No Abstract] [Full Text] [Related]
19. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.
Meade TW; Greenberg G; Thompson SG
Br Med J; 1980 May; 280(6224):1157-61. PubMed ID: 7388443
[TBL] [Abstract][Full Text] [Related]
20. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
